Armata Pharmaceuticals (ARMP) Current Assets (2013 - 2026)

Armata Pharmaceuticals (ARMP) has 14 years of Current Assets data on file, last reported at $5.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 54.84% year-over-year to $5.9 million; the trailing twelve-month figure through Mar 2026 stood at $5.9 million (down 54.84% YoY), and the FY2025 full-year result was $10.7 million, down 5.66% from the prior year.
• Current Assets retreated to $5.9 million in Q1 2026, from $10.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $48.7 million in Q1 2022 to a low of $5.9 million in Q1 2026.
• A 5-year average of $25.4 million and a median of $26.8 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 134.48% in 2022 and slumped 75.67% in 2025, its largest moves.
• Tracing ARMP's Current Assets over 5 years: stood at $27.0 million in 2022, then decreased by 29.19% to $19.2 million in 2023, then plunged by 40.95% to $11.3 million in 2024, then declined by 5.66% to $10.7 million in 2025, then plunged by 44.26% to $5.9 million in 2026.
• Business Quant data shows ARMP's Current Assets at $5.9 million in Q1 2026, $10.7 million in Q4 2025, and $16.9 million in Q3 2025.